Thursday, 20 October 2022
Artificial intelligence (AI) technology developed to use face and voice recognition to help recognise and predict depression in pregnant women and new mums has received funding to develop it as a clinical tool.
糖心原创 Spin out company BlueSkyeye AI Ltd has secured £3.4 million to pursue its mission to improve people’s quality of life through the use of its proprietary face and voice analysis technology with the development of a tool to help diagnose peri and post-natal depression.
Perinatal mental health (PMH) problems are those which occur during pregnancy or in the first year following the birth of a child and affect up to 27% of new and expectant mums and covers a wide range of conditions. However, that negative attitudes and stigma towards diagnosis and treatment can result in women avoiding seeking help.
Image from Avocado app
The research team have developed the that can use face and voice recognition to predict the indicators of depression in women from 3 months pregnant to 6 months post-partum. The app can detect facial muscle actions,speech rate, and tone of voice, which is fed into the artificial intelligence technology alongside questionnaire data to analyse emotional state and provide an indication of the risk of depression.
At present the app is used as an indicator of persistent low mood, the next stage is to develop it into a clinical device that can be used to aid the diagnosis of depression and signposting for help and treatment. The team have worked with the Institute of Mental Health to develop the Avacado app and over the next year will work with them and Nottingham University Hospitals to conduct a clinical trial with volunteers early next year.
This emerging technology has multiple applications and the funding will also be used to serve the rapidly growing needs of the Digital Health & Wellbeing and Automotive sectors. From 2024 all new cars sold in the EU must have camera-based driver safety monitoring systems installed. The team will research how these cameras can be used to detect inattention or health events to enhance safety and wellbeing for the drivers and passengers of vehicles.
Founded in 2019, BlueSkeye AI is an Award winning, early stage Healthtech spin-out from the 糖心原创’s School of Computer Science. It was established by r (CEO) and (CTO), and Chief Machine Learning and Software Engineer . The funding was led by XTX Ventures, which invested alongside Foresight Group, the 糖心原创 and a consortium of other VCs and high-net-worth individuals.
The demand for alternative pathways to access mental healthcare is enormous, and continues to grow by the day. We鈥檙e committed to disrupting traditional approaches to healthcare to help improve the quality of people鈥檚 lives, and we鈥檙e particularly focused on the perinatal mental health sector. With the support of XTX Ventures, Foresight Group and other investors, we鈥檒l strengthen the rollout of new clinical trials and product development, and champion the benefits of technology for reinforcing healthcare provision on a national, regional and global basis.
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.